(1)
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization
VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou.
The project commenced in 2017, is designed to deliver a gene and protein expression map of healthy hair follicle cells expected to be critically important to improving key components of the manufacturing, regulatory, and clinical profile of RepliCel s cell therapy products.
A hot topic symposia session during the Pediatric Academic Societies (PAS) 2021 Virtual Meeting will address the persistent controversies and questions in preterm infant nutrition.
E-Mail
IMAGE: The Pediatric Academic Societies (PAS) Meeting connects thousands of pediatricians and other health care providers worldwide. view more
Credit: PAS
A hot topic symposia session during the Pediatric Academic Societies (PAS) 2021 Virtual Meeting will address the persistent controversies and questions in preterm infant nutrition.
After six years of interdisciplinary expert discussion and critical evidence review, the 2014 vision to develop evidence-informed guidance for the nutritional care of preterm infants has come to fruition. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Academy of Nutrition and Dietetics (AND) initiated this multiphase process involving expert physician, dietitian, and pharmacology scientists.
Updated 5/5/2021 9:16 AM
A DuPage County judge has ordered Elmhurst Hospital to allow a 68-year-old woman fighting COVID-19 to be treated with a drug not approved for such use by the Food and Drug Administration.
Judge James Orel on Friday signed an emergency order directing the hospital to give ivermectin an anti-parasitic drug to Nurije Fype of Elmhurst, who is on a ventilator and in a coma. But doctors at the hospital don t want to comply.
On Monday, a visibly angry Orel raised his voice during a hearing on the case. My order was, Get out of the way and let the prescription be served, he said. That s it.
Hunter Biden to guest-lecture a fake news media course at Tulane University americanthinker.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from americanthinker.com Daily Mail and Mail on Sunday newspapers.